These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 772647)

  • 21. [Verapamil versus propranolol in stable effort angina. Randomized, crossed, double-blind study].
    Lesbre JP; Lalau JD; Jaubourg ML; Maarek-Charbit M
    Ann Cardiol Angeiol (Paris); 1988 Apr; 37(4):205-10. PubMed ID: 3285763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Verapamil in the treatment of angina pectoris. Double-blind study with clinical-cycloergometric correlation].
    Maranhão MF; Lopes M; Toledo MT; Rojas RI; Michelotto PV; Michelotto PV; Lacerda FS; Furlan L; Cunha GP; Oliveira PF
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():95-9. PubMed ID: 329814
    [No Abstract]   [Full Text] [Related]  

  • 23. [Drug therapy of coronary heart disease (author's transl)].
    Kaltenbach M
    Arzneimittelforschung; 1977; 27(3a):703-7. PubMed ID: 17415
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cycloergometric evaluation of the effects of verapamil in chronic coronary insufficiency].
    Meneghelo RS; Duprat R; Batlouni M; Severino CA; Armaganijan D; Magalhães HM; Feher J
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():59-63. PubMed ID: 329809
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of antianginal actions of verapamil and propranolol.
    Bowles MJ; Subramanian VB; Davies AB; Raftery EB
    Br Med J (Clin Res Ed); 1981 May; 282(6278):1754. PubMed ID: 6786607
    [No Abstract]   [Full Text] [Related]  

  • 26. [Double-blind comparison of verapamil and propranolol in the therapy of unstable angina].
    Capucci A; Bracchetti D; Carini G; Di Ciò G; Maresta A; Magnani B
    Cardiologia; 1982; 27(5):447-52. PubMed ID: 6765439
    [No Abstract]   [Full Text] [Related]  

  • 27. Superiority of verapamil to propranolol in stable angina pectoris: a double-blind, randomized crossover trail.
    Frishman WH; Klein NA; Strom JA; Willens H; LeJemtel TH; Jentzer J; Siegel L; Klein P; Kirschen N; Silverman R; Pollack S; Doyle R; Kirsten E; Sonnenblick EH
    Circulation; 1982 Jan; 65(1 Pt 2):I51-9. PubMed ID: 6796289
    [No Abstract]   [Full Text] [Related]  

  • 28. [Verapamil or propranolol for the treatment of angina pectoris].
    Hansen JF; Grytter C; Thomsen S; Sigurd B
    Ugeskr Laeger; 1982 Jan; 144(4):240-3. PubMed ID: 7041382
    [No Abstract]   [Full Text] [Related]  

  • 29. [Ergometric evaluation of the therapeutic effect of prolonged oral administration of delayed-action verapamil on 20 patients with stable effort angina].
    Martiny W; Bottone W; Matta F; Cerrone G; Minelli M; Angelino PF
    Minerva Cardioangiol; 1978 Dec; 26(12):811-8. PubMed ID: 368679
    [No Abstract]   [Full Text] [Related]  

  • 30. [Double-blind comparison between verapamil and propranolol in the therapy of unstable angina].
    Capucci A; Bracchetti D; Carini G; Di Ciò G; Maresta A; Magnani B
    Cardiologia; 1982; 27(5):447-52. PubMed ID: 6821377
    [No Abstract]   [Full Text] [Related]  

  • 31. Investigation of verapamil in the treatment of angina pectoris.
    Sandler G
    Brux Med; 1970 Sep; 50(9):669-73. PubMed ID: 4928626
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of non-invasive methods in clinical evaluation of drugs in ischaemic heart disease.
    Chlebus H
    Bibl Cardiol; 1976; (35):167-71. PubMed ID: 825097
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antia-angina effect of verapamil through the clinical and ergometric evaluation].
    Castro I; Pereira FA; Rodrigues R
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():75-7. PubMed ID: 329812
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of verapamil on echocardiographic dimensions of the left ventricle in ischemic cardiopathy: comparison with placebo, propranolol and trinitroglycerin].
    Fonzo R; Cherchi A; Bina P; Mercuro G; Lai C; Cioglia G; Sau F
    Boll Soc Ital Cardiol; 1979; 24(6):623-35. PubMed ID: 121796
    [No Abstract]   [Full Text] [Related]  

  • 35. [Assessment of therapeutic effects of Verapamil by means of an exercise test].
    Goch JH; Rec A; Bala T
    Pol Tyg Lek; 1975 Sep; 30(36):1497-8. PubMed ID: 1161614
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparative pharmacodynamics study of korinfar and isoptin in ischemic heart disease].
    Savvateev KL; Shinbaeva NA; Vygodin VA; Nikolenko SA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(1):64-70. PubMed ID: 7259869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemodynamic effects of propranolol in coronary heart disease.
    Parker JO; West RO; Di Giorgi S
    Am J Cardiol; 1968 Jan; 21(1):11-9. PubMed ID: 5634737
    [No Abstract]   [Full Text] [Related]  

  • 38. Additive antianginal effect of verapamil in patients receiving propranolol.
    Bassan M; Weiler-Ravell D; Shalev O
    Br Med J (Clin Res Ed); 1982 Apr; 284(6322):1067-70. PubMed ID: 6802408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized double-blind comparison of the effects of isosorbide dinitrate retard, verapamil sustained-release, and their combination on myocardial ischemic episodes.
    Friedensohn A; Meshulam R; Schlesinger Z
    Cardiology; 1991; 79 Suppl 2():31-40. PubMed ID: 1760827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Verapamil in chronic stable angina: a controlled study with computerized multistage treadmill exercise.
    Bala Subramanian V; Lahiri A; Parmasivan R; Raftery EB
    Clin Invest Med; 1980; 3(1-2):111-8. PubMed ID: 6781805
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.